By suppressing autophagy in EMT-like CD133+ cells, it is possible to reinstate their responsiveness to apoptosis, therefore decreasing the occurrence of metastasis and inhibiting tumor advancement [127]. This evidence concerns the gene PROM1 and neoplasm.